177 related articles for article (PubMed ID: 17329548)
1. Interaction of endothelial nitric oxide and angiotensin in the circulation.
Toda N; Ayajiki K; Okamura T
Pharmacol Rev; 2007 Mar; 59(1):54-87. PubMed ID: 17329548
[TBL] [Abstract][Full Text] [Related]
2. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
Schulman IH; Zhou MS; Raij L
J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
Bauer V; Sotníková R
Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.
Schlüter KD; Wenzel S
Pharmacol Ther; 2008 Sep; 119(3):311-25. PubMed ID: 18619489
[TBL] [Abstract][Full Text] [Related]
5. Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat.
Yang R; Smolders I; De Bundel D; Fouyn R; Halberg M; Demaegdt H; Vanderheyden P; Dupont AG
J Hypertens; 2008 May; 26(5):998-1007. PubMed ID: 18398343
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers, endothelial dysfunction, and combination therapy.
Schulman IH; Zachariah M; Raij L
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and vascular inflammation.
Cheng ZJ; Vapaatalo H; Mervaala E
Med Sci Monit; 2005 Jun; 11(6):RA194-205. PubMed ID: 15917731
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide.
Yayama K; Okamoto H
Int Immunopharmacol; 2008 Feb; 8(2):312-8. PubMed ID: 18182246
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.
Bottari SP; de Gasparo M; Steckelings UM; Levens NR
Front Neuroendocrinol; 1993 Apr; 14(2):123-71. PubMed ID: 8486206
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics.
Arima S
Clin Exp Nephrol; 2003 Sep; 7(3):172-8. PubMed ID: 14586712
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s).
Batenburg WW; Tom B; Schuijt MP; Danser AH
Vascul Pharmacol; 2005 Feb; 42(3):109-18. PubMed ID: 15792928
[TBL] [Abstract][Full Text] [Related]
12. The CNS renin-angiotensin system.
von Bohlen und Halbach O; Albrecht D
Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
[TBL] [Abstract][Full Text] [Related]
13. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols.
Walter A; Etienne-Selloum N; Sarr M; Kane MO; Beretz A; Schini-Kerth VB
J Vasc Res; 2008; 45(5):386-94. PubMed ID: 18354258
[TBL] [Abstract][Full Text] [Related]
15. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
Gibbons GH
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
Dandona P; Dhindsa S; Ghanim H; Chaudhuri A
J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-nitric oxide interaction in the kidney.
Patzak A; Persson AE
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):46-51. PubMed ID: 17143071
[TBL] [Abstract][Full Text] [Related]
18. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
[TBL] [Abstract][Full Text] [Related]
19. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes.
Weiland F; Verspohl EJ
Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690
[TBL] [Abstract][Full Text] [Related]
20. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice.
Vinh A; Widdop RE; Drummond GR; Gaspari TA
Cardiovasc Res; 2008 Jan; 77(1):178-87. PubMed ID: 18006471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
